A vitamin A byproduct has been found to quietly disarm the immune system, allowing tumors to evade attack and weakening ...

Durable complete responses with CAR-NK + Rituximab in patients who failed current standards of care in Waldenstrom’s ...

ImmunityBio’s Anktiva receives Saudi FDA approval for non-muscle invasive bladder cancer with carcinoma in-situ: Culver City, California Friday, January 16, 2026, 15:00 Hrs [IST ...

Scientists have discovered that the adolescent brain does more than prune old connections. During the teen years, it actively ...

ImmunityBio, Inc. today announced an update on the status of enrollment in its randomized registrational trial in BCG-naïve ...

This article explores how next-generation vaccines are expanding beyond infectious disease to target chronic conditions while ...